US 11111235
Compounds, compositions, and methods
granted A61PA61P1/04A61P19/02
Quick answer
US patent 11111235 (Compounds, compositions, and methods) held by DENALI THERAPEUTICS INC. expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P1/04, A61P19/02, A61P21/00, A61P25/00